BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 32950990)

  • 1. The Impact of Smoking Cessation and Continuation on Recurrence and Survival in Patients with Head and Neck Cancer: A Systematic Review of the Literature.
    von Kroge PR; Bokemeyer F; Ghandili S; Bokemeyer C; Seidel C
    Oncol Res Treat; 2020; 43(10):549-558. PubMed ID: 32950990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of smoking status, disease stage, and index tumor site on second primary tumor incidence and tumor recurrence in the head and neck retinoid chemoprevention trial.
    Khuri FR; Kim ES; Lee JJ; Winn RJ; Benner SE; Lippman SM; Fu KK; Cooper JS; Vokes EE; Chamberlain RM; Williams B; Pajak TF; Goepfert H; Hong WK
    Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):823-9. PubMed ID: 11489748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of continued smoking on survival and recurrence rates in patients with head and neck cancer: A systematic review.
    van Imhoff LC; Kranenburg GG; Macco S; Nijman NL; van Overbeeke EJ; Wegner I; Grolman W; Pothen AJ
    Head Neck; 2016 Apr; 38 Suppl 1():E2214-20. PubMed ID: 25900211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Social environment, secondary smoking exposure, and smoking cessation among head and neck cancer patients.
    Kashigar A; Habbous S; Eng L; Irish B; Bissada E; Irish J; Brown D; Gilbert R; Gullane P; Xu W; Huang SH; Witterick I; Freeman J; O'Sullivan B; Waldron J; Liu G; Goldstein D
    Cancer; 2013 Aug; 119(15):2701-9. PubMed ID: 23765604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative smoking cessation: impact on perioperative and long-term complications.
    Wein RO
    Arch Otolaryngol Head Neck Surg; 2009 Jun; 135(6):597-601. PubMed ID: 19528409
    [No Abstract]   [Full Text] [Related]  

  • 6. The risk of second primary tumors in head and neck cancer: A systematic review.
    Coca-Pelaz A; Rodrigo JP; Suárez C; Nixon IJ; Mäkitie A; Sanabria A; Quer M; Strojan P; Bradford CR; Kowalski LP; Shaha AR; de Bree R; Hartl DM; Rinaldo A; Takes RP; Ferlito A
    Head Neck; 2020 Mar; 42(3):456-466. PubMed ID: 31750595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does Quitting Smoking Make a Difference Among Newly Diagnosed Head and Neck Cancer Patients?
    Choi SH; Terrell JE; Bradford CR; Ghanem T; Spector ME; Wolf GT; Lipkus IM; Duffy SA
    Nicotine Tob Res; 2016 Dec; 18(12):2216-2224. PubMed ID: 27613928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of continued smoking in head and neck cancer patients treated with radiotherapy: A systematic review and meta-analysis.
    Smith J; Nastasi D; Tso R; Vangaveti V; Renison B; Chilkuri M
    Radiother Oncol; 2019 Jun; 135():51-57. PubMed ID: 31015170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
    Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
    Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prior chemoradiotherapy adversely impacts outcomes of recurrent and second primary head and neck cancer treated with concurrent chemotherapy and reirradiation.
    Choe KS; Haraf DJ; Solanki A; Cohen EE; Seiwert TY; Stenson KM; Blair EA; Portugal L; Villaflor VM; Witt ME; Vokes EE; Salama JK
    Cancer; 2011 Oct; 117(20):4671-8. PubMed ID: 21671479
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D intake and survival and recurrence in head and neck cancer patients.
    Yokosawa EB; Arthur AE; Rentschler KM; Wolf GT; Rozek LS; Mondul AM
    Laryngoscope; 2018 Nov; 128(11):E371-E376. PubMed ID: 29756240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between antioxidant vitamin supplementation and cigarette smoking during radiation therapy in relation to long-term effects on recurrence and mortality: a randomized trial among head and neck cancer patients.
    Meyer F; Bairati I; Fortin A; Gélinas M; Nabid A; Brochet F; Têtu B
    Int J Cancer; 2008 Apr; 122(7):1679-83. PubMed ID: 18059031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-diagnosis smoking cessation and survival of patients with head and neck cancer: a systematic review and meta-analysis.
    Caini S; Del Riccio M; Vettori V; D'Ecclesiis O; Bonomo P; Locatello LG; Salvestrini V; Gallo O; Tagliabue M; Raimondi S; Saieva C; Cozzolino F; Bendinelli B; Gandini S
    Br J Cancer; 2022 Nov; 127(11):1907-1915. PubMed ID: 35999273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Comprehensive Analysis on the Association between Tobacco-Free Betel Quid and Risk of Head and Neck Cancer in Taiwanese Men.
    Wu YH; Yen CJ; Hsiao JR; Ou CY; Huang JS; Wong TY; Tsai ST; Huang CC; Lee WT; Chen KC; Fang SY; Wu JL; Hsueh WT; Lin FC; Yang MW; Chang JY; Liao HC; Wu SY; Lin CL; Wang YH; Weng YL; Yang HC; Chen YS; Chang JS
    PLoS One; 2016; 11(10):e0164937. PubMed ID: 27780233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrence patterns with concurrent platinum-based chemotherapy and accelerated hyperfractionated radiotherapy in stage III and IV head and neck cancer patients.
    Koness RJ; Glicksman A; Liu L; Coachman N; Landman C; Slotman G; Wanebo HJ
    Am J Surg; 1997 Nov; 174(5):532-5. PubMed ID: 9374231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pretreatment screening on distant metastases and head and neck cancer patients: Validation of risk factors and influence on survival.
    Peters TT; Senft A; Hoekstra OS; Castelijns JA; Witte BI; Leemans CR; de Bree R
    Oral Oncol; 2015 Mar; 51(3):267-71. PubMed ID: 25552384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tobacco smoking during radiation therapy for head-and-neck cancer is associated with unfavorable outcome.
    Chen AM; Chen LM; Vaughan A; Sreeraman R; Farwell DG; Luu Q; Lau DH; Stuart K; Purdy JA; Vijayakumar S
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):414-9. PubMed ID: 20399030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment Modality and Second Primary Tumors of the Head and Neck.
    Ben Arie G; Shafat T; Belochitski O; El-Saied S; Joshua BZ
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(6):420-427. PubMed ID: 34587611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival analysis of head and neck squamous cell carcinoma: influence of smoking and drinking.
    Farshadpour F; Kranenborg H; Calkoen EV; Hordijk GJ; Koole R; Slootweg PJ; Terhaard CH
    Head Neck; 2011 Jun; 33(6):817-23. PubMed ID: 20737489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 expressions: predicting recurrence and second primary tumors in head and neck squamous cell carcinoma.
    Shin DM; Lee JS; Lippman SM; Lee JJ; Tu ZN; Choi G; Heyne K; Shin HJ; Ro JY; Goepfert H; Hong WK; Hittelman WN
    J Natl Cancer Inst; 1996 Apr; 88(8):519-29. PubMed ID: 8606380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.